These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 7967969)

  • 1. [Can insulin-dependent diabetes be cured? More research on GAD autoimmunity is necessary].
    Lernmark A
    Lakartidningen; 1994 Nov; 91(44):3977-80. PubMed ID: 7967969
    [No Abstract]   [Full Text] [Related]  

  • 2. Autoimmunity to CD38 and GAD in Type I and Type II diabetes: CD38 and HLA genotypes and clinical phenotypes.
    Antonelli A; Tuomi T; Nannipieri M; Fallahi P; Nesti C; Okamoto H; Groop L; Ferrannini E
    Diabetologia; 2002 Sep; 45(9):1298-306. PubMed ID: 12242463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Autoimmunity and glutamate decarboxylase antibodies in the pathogenesis of type I diabetes mellitus in experimental and clinical practice].
    Kucera P; Andĕl M; Treslová L
    Vnitr Lek; 1996 May; 42(5):359-67. PubMed ID: 8768297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T cell autoimmunity to glutamic acid decarboxylase in human insulin-dependent diabetes mellitus.
    Lohmann T; Scherbaum WA
    Horm Metab Res; 1996 Jul; 28(7):357-60. PubMed ID: 8858386
    [No Abstract]   [Full Text] [Related]  

  • 5. Lack of autoimmune serological reactions in rodent models of insulin dependent diabetes mellitus.
    Mackay IR; Bone A; Tuomi T; Elliott R; Mandel T; Karopoulos C; Rowley MJ
    J Autoimmun; 1996 Dec; 9(6):705-11. PubMed ID: 9115572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoantibodies associated with presymptomatic insulin-dependent diabetes mellitus in women.
    Whittingham S; Byron SL; Tuomilehto J; Zimmet PZ; Myers MA; Vidgren G; Rowley MJ; Feeney SJ; Koskela P; Tuomilehto-Wolf E; Mackay IR
    Diabet Med; 1997 Aug; 14(8):678-85. PubMed ID: 9272595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. For debate: are we ready for GAD-vaccination in the treatment and/or prevention of type 1 diabetes?
    Ludvigsson J
    Pediatr Endocrinol Rev; 2008 Jun; 5(4):871-2. PubMed ID: 18552748
    [No Abstract]   [Full Text] [Related]  

  • 8. Development and progression of diabetic retinopathy in patients with Type 1 diabetes who are positive for GAD autoantibody.
    Mimura T; Funatsu H; Uchigata Y; Kitano S; Shimizu E; Noma H; Amano S; Araie M; Iwamoto Y; Hori S
    Diabet Med; 2004 Jun; 21(6):559-62. PubMed ID: 15154939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical evaluation of non-insulin-dependent diabetes mellitus patients with autoantibodies to glutamic acid decarboxylase.
    Abiru N; Takino H; Yano M; Kawasaki E; Yamasaki H; Yamaguchi Y; Akazawa S; Nagataki S
    J Autoimmun; 1996 Oct; 9(5):683-8. PubMed ID: 8933285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD8+ T lymphocytes specific for glutamic acid decarboxylase 90-98 epitope mediate diabetes in NOD SCID mouse.
    Sévère S; Gauvrit A; Vu AT; Bach JM
    Mol Immunol; 2007 Apr; 44(11):2950-60. PubMed ID: 17336387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Demonstration of GAD-65 as the main immunogenic isoform of glutamate decarboxylase in type 1 diabetes and determination of autoantibodies using a radioligand produced by eukaryotic expression.
    Velloso LA; Kämpe O; Hallberg A; Christmanson L; Betsholtz C; Karlsson FA
    J Clin Invest; 1993 May; 91(5):2084-90. PubMed ID: 8486775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glutamic acid decarboxylase autoantibody prevalence and association with HLA genotype in patients with younger-onset type 1 diabetes and proliferative diabetic retinopathy.
    Mimura T; Funatsu H; Uchigata Y; Kitano S; Shimizu E; Amano S; Yamagami S; Noma H; Araie M; Hori S
    Ophthalmology; 2005 Nov; 112(11):1904-9. PubMed ID: 16157380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High prevalence of antibodies to glutamic acid decarboxylase in comparison to islet cell antibodies in patients with long-standing insulin-dependent diabetes mellitus.
    Imagawa A; Itoh N; Hanafusa T; Katsura H; Yamaguchi A; Takeda A; Iwahashi H; Nakajima H; Miyagawa J; Namba M; Kuwajima M; Matsuzawa Y
    Res Commun Mol Pathol Pharmacol; 1996 Apr; 92(1):43-52. PubMed ID: 8733827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does GAD have a unique role in triggering IDDM?
    Baekkeskov S; Kanaani J; Jaume JC; Kash S
    J Autoimmun; 2000 Nov; 15(3):279-86. PubMed ID: 11040068
    [No Abstract]   [Full Text] [Related]  

  • 15. Heterogeneity of islet cell cytoplasmic antibodies and autoantibodies to glutamate decarboxylase in relatives of patients with type 1 (insulin-dependent) diabetes.
    Bergerot I; Souchier C; Thivolet C
    C R Acad Sci III; 1993 Nov; 316(11):1368-73. PubMed ID: 8087616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoreactive T cells in human type 1 diabetes.
    Tree TI; Peakman M
    Endocrinol Metab Clin North Am; 2004 Mar; 33(1):113-33, ix-x. PubMed ID: 15053898
    [No Abstract]   [Full Text] [Related]  

  • 17. Signs of beta-cell autoimmunity and HLA-defined diabetes susceptibility in the Finnish population: the sib cohort from the Type 1 Diabetes Prediction and Prevention Study.
    Kukko M; Kimpimäki T; Kupila A; Korhonen S; Kulmala P; Savola K; Simell T; Keskinen P; Ilonen J; Simell O; Knip M
    Diabetologia; 2003 Jan; 46(1):65-70. PubMed ID: 12637984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and clinical characteristics of insulin-treated, anti-GAD-positive, type 2 diabetic subjects in an outpatient clinical department of a Dutch teaching hospital.
    Römkens TE; Kusters GC; Netea MG; Netten PM
    Neth J Med; 2006 Apr; 64(4):114-8. PubMed ID: 16609158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GAD, diabetes, and Stiff-Man syndrome: some progress and more questions.
    Solimena M; Butler MH; De Camilli P
    J Endocrinol Invest; 1994; 17(7):509-20. PubMed ID: 7829825
    [No Abstract]   [Full Text] [Related]  

  • 20. The clinical significance of an autoimmune response against glutamic acid decarboxylase.
    Ellis TM; Atkinson MA
    Nat Med; 1996 Feb; 2(2):148-53. PubMed ID: 8574952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.